Epidemiology of Huntington's disease in Finland

Parkinsonism and Related Disorders

Volumn 21, Issue 1, 2015, Pages 46-49

  Sipilä, Jussi O T ^a,b   Hietala, Marja ^a   Siitonen, Ari ^c,d   Päivärinta, Markku ^e   Majamaa, Kari ^c,d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e Regional Cancer Center   (Sweden)

Author keywords

Choreatic disorders; Clinical neurology; Hereditary neurodegenerative diseases; Neuroepidemiology

Indexed keywords

HUNTINGTIN; HTT PROTEIN, HUMAN; NERVE PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAG REPEAT; DISEASE DURATION; FEMALE; FINLAND; HAPLOGROUP; HUMAN; HUNTINGTIN GENE; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; GENETICS; HUNTINGTON DISEASE; LONGITUDINAL STUDY; MIDDLE AGED; NONPARAMETRIC TEST; RETROSPECTIVE STUDY; TRINUCLEOTIDE REPEAT; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; FINLAND; HUMANS; HUNTINGTON DISEASE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PREVALENCE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84918503352     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.10.025     Document Type: Article

References (28)

1. Walker F.O. Huntington's disease. Lancet 2007, 369:218-228.
2. Anovel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983. The Huntington's Disease Collaborative Research Group.
3. Ranen N.G., Stine O.C., Abbott M.H., Sherr M., Codori A.M., Franz M.L., et al. Anticipation and instability of IT-15 (CAG)N repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet 1995, 57:593-602.
4. Novak M.J.U., Tabrizi S.J. Huntington's disease. BMJ 2010, 341:34-40.
5. Pringsheim T., Wiltshire K., Day L., Dykeman J., Steeves T., Jette N. The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Dis 2012, 23:1083-1091.
6. Evans S.J.V., Douglas I., Rawlins M., Wexler N.S., Tabrizi S.J., Smeeth L. Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records. JNeurol Neurosurg Psychiatry 2013, 84:1156-1160.
7. Fisher E.R., Hayden M.R. Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk. Mov Dis 2014, 29:105-114.
8. Warby S.C., Montpetit A., Hayden A.R., Carroll J.B., Butland S.L., Visscher H., et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 2009, 84:351-366.
9. Palo J., Somer H., Ikonen E., Karila L., Peltonen L. Low prevalence of Huntington's disease in Finland. Lancet 1987, 8562:805-806.
10. Ikonen E., Ignatius J., Norio R., Palo J., Peltonen L. Huntington disease in Finland: a molecular and genealogical study. Hum Genet 1992, 89:275-280.
11. Ikonen E., Palo J., Ott J., Gusella J., Somer H., Karila L., et al. Huntington disease in Finland: linkage disequilibrium of chromosome 4 RFLP haplotypes and exclusion fo a tight linkage between the disease and the D4S43 locus. Am J Hum Genet 1990, 46:5-11.
12. Palo J.U., Ulmanen I., Lukka M., Ellonen P., Sajantila A. Genetic markers and population history: Finland revisited. Eur J Hum Genet 2009, 17:1336-1346.
13. Newcombe R.G. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998, 17:857-872.
14. McGrogan A., Madle G.C., Seaman H.E., de Vries C.S. The epidemiology of Guillain-Barré syndrome worldwide. Neuroepidemiology 2009, 32:150-163.
15. Tassicker R.J., Teltscher B., Trembath M.K., Collins V., Sheffield L.J., Chiu E., et al. Problems assessing uptake of Huntington disease predictive testing and a proposed solution. Eur J Hum Genet 2009, 17:66-70.
16. Morrison P.J., Harding-Lester S., Bradley A. Uptake of Huntington disease predictive testing in a complete population. Clin Genet 2011, 80:281-286.
17. Ramos-Arroyo M.A., Moreno S., Valiente A. Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing. JNeurol Neurosurg Psychiatry 2005, 76:337-342.
18. Rinaldi C., Salvatore E., Giordano I., De Matteis S., Tucci T., Cinzia V.R., et al. Predictors of survival in a Huntington's disease population from southern Italy. Can J Neurol Sci 2012, 39:48-51.
19. Panas M., Karadima G., Vassos E., Kalfakis N., Kladi A., Christodoulou K., et al. Huntington's disease in Greece: the experience of 14 years. Clin Genet 2011, 80:586-590.
20. Sveinsson Ó., Halldórsson S., Olafsson E. An unusually low prevalence of Huntington's disease in Iceland. Eur Neurol 2012, 68:48-51.
21. Cavalli-Sforza L.L., Piazza A. Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet 1993, 1:3-18.
22. Salmela E., Lappalainen T., Fransson I., Andersen P.M., Dahlman-Wright K., Fiebig A., et al. Genome-wide analysis of single nucleotide polymorphisms uncovers population structure in northern Europe. PLoS One 2008, 3:e3519.
23. Sund R. Quality of the Finnish hospital discharge register: a systematic review. Scand J Pub Health 2012, 40:505-515.
24. Vuorenkoski L., Mladovsky P., Mossialos E. Finland: health system review. Health Syst Trans 2008, 10:97-119.
25. St Germaine-Smith C., Metcalfe A., Pringsheim T., Roberts J.I., Beck C.A., Hemmelgarn B.R., et al. Recommendations for optimal ICD codes to study neurologic conditions. Neurology 2012, 79:1049-1055.
26. Laccone F., Engel U., Holinski-Feder U., Weigell-Weber M., Marczinek K., Nolte D., et al. DNA analysis of Huntington's disease: five years of experience in Germany, Austria and Switzerland. Neurology 1999, 53:801-806.
27. Benitez J., Fernandez E., Garcia Ruiz P., Robledo M., Ramos C., Yébenes J. Trinucleotide (CAG) repeat expansion in chromosomes of Spanish patients with Huntington's disease. Hum Genet 1994, 94:563-564.
28. Langbehn D.R., Hayden M., Paulsen J.S. CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:397-408. PREDICT-HD Investigators of the Huntington Study Group.